Skip to main content
Menu Close
Home
Presented by
  • About Us
  • Register or Login
Home
Full Menu Full Menu
  • Acute Coronary Syndromes
  • Arrhythmias & EP
  • DVT/VTE
  • News
  • Commentary

Conference Coverage

Digital alerts reduced AF-related stroke, MI rates

Author:
Richard Mark Kirkner
Publish date: December 18, 2018

CHICAGO – A computerized decision support system increased anticoagulation rates and reduced cardiac event rates in at-risk atrial fibrillation...

  • Read More

Conference Coverage

Phase 3 data support apixaban for cancer-associated VTE

Author:
Jennifer Smith
Publish date: December 13, 2018

The rate of major bleeding was similar with apixaban and dalteparin.

  • Read More

MD IQ

Quiz: Managing AF with oral anticoagulant therapy

Conference Coverage

Thrombectomy shows efficacy for basilar artery strokes

Author:
Mitchel L. Zoler
Publish date: December 7, 2018

MONTREAL – A randomized trial got derailed by underrecruitment and crossovers, but still showed evidence of thrombectomy’s efficacy.

  • Read More

Conference Coverage

Large cohort study IDs prognostic factors in thromboangiitis obliterans

Author:
Sharon Worcester
Publish date: December 5, 2018

CHICAGO – Ethnicity and limb infection are independent predictors of poor outcomes, including limb amputation, in TAO.

  • Read More

From the Journals

AVERT: Apixaban reduced thromboembolism risk in cancer patients

Author:
Bianca Nogrady
Publish date: December 4, 2018

Cancer patients treated with apixaban had a significantly lower rate of venous thromboembolism but a higher risk of major bleeds than did those...

  • Read More

Video

ARISTOPHANES: Apixaban edges other DOACS for octogenarians

Author:
Mitchel L. Zoler
Publish date: December 2, 2018

CHICAGO – Insurance claims data from more than 50,000 U.S. octogenarians on a DOAC showed apixaban worked best and caused the fewest major bleeds...

  • Read More

Conference Coverage

CT opens extended window for stroke thrombolysis

Author:
Mitchel L. Zoler

MONTREAL – The new EXTEND findings “will have a major impact” on using an extended time window for thrombolysis in U.S. practice.

  • Read More

Conference Coverage

GARFIELD-AF registry: DOACs cut mortality 19%

Author:
Mitchel L. Zoler
Publish date: October 10, 2018

MUNICH – Results from a worldwide registry with more than 26,000 atrial fibrillation patients showed better survival with a direct oral...

  • Read More

From the Journals

Atrial fib guidelines may fall short on oral anticoagulation

Author:
Amy Karon
Publish date: September 25, 2018

Oral anticoagulation threshold according to CHA2DS2-VASc score varied widely after accounting for varying stroke rates in published studies.

  • Read More

From the Journals

Expert panel updates guidelines on antithrombotic therapy for AF

Author:
Andrew D. Bowser
Publish date: September 18, 2018

The new guidelines highlight 60 key recommendations from the 12-person expert panel.

  • Read More

News

New stroke intervention guidelines stress volume

Author:
Jim Kling
Publish date: September 12, 2018

New guidelines set minimum procedures per year for level 1 and level 2 stroke centers, but leave some wiggle...

  • Read More

Conference Coverage

Synergy DES shines in acute MI

Author:
Bruce Jancin
Publish date: July 28, 2018

PARIS – Swedish registry report analyzes key clinical outcomes in more than 36,000 consecutive acute MI patients who received newer-generation...

  • Read More

Conference Coverage

How to identify DVT faster in pediatric osteomyelitis

Author:
Bruce Jancin
Publish date: July 18, 2018

MALMO, SWEDEN – Recognition of key risk factors warrants early screening ultrasound.

  • Read More

From the Journals

Obesity triples post-MI sudden cardiac death risk

Author:
Bianca Nogrady
Publish date: July 11, 2018

The obesity paradox makes a showing in the risk of all-cause death.

  • Read More

MD IQ

Quiz: Left atrial appendage & AF treatment

News

Alteplase, aspirin provide similar functional outcomes after nondisabling stroke

Author:
Sharon Worcester
Publish date: July 10, 2018

PRISMS trial results suggest that alteplase offers no benefit over aspirin for functional outcomes after...

  • Read More

From the Journals

New look at ATLAS suggests rivaroxaban may still have role in ACS

Author:
Michele G. Sullivan
Publish date: July 2, 2018

A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.

  • Read More

Conference Coverage

Amplatzer Amulet slashes stroke risk in A-fib

Author:
Bruce Jancin
Publish date: June 27, 2018

PARIS – “Given the high bleeding risk, single antiplatelet therapy seems to be a good option for these patients,” said Dr. Ulf Landmesser.

  • Read More

MD IQ

Quiz: AF prominence & population

Conference Coverage

Design limitations may have compromised DVT intervention trial

Author:
Ted Bosworth
Publish date: May 14, 2018

WASHINGTON – The preferred evaluation – intravascular ultrasound – was not used.

  • Read More

News

First reversal agent for apixaban and rivaroxaban gets fast-track approval

Author:
Catherine Hackett
Publish date: May 4, 2018

Andexanet alfa approval puts factor Xa inhibitors in the same ballpark as dabigatran, reversible with idarucizumab.

  • Read More

Conference Coverage

Does warfarin cause acute kidney injury?

Author:
Doug Brunk
Publish date: May 2, 2018

SAN DIEGO – Consider increased monitoring of renal function in certain patients.

  • Read More

From the Journals

Women’s representation in CV drug trials still lagging

Author:
Andrew D. Bowser
Publish date: April 30, 2018

We’ve come a long way in clinical trial representation of women, but there’s more work to do.

  • Read More

Conference Coverage

  • Digital alerts reduced AF-related stroke, MI rates
    Publish date: December 18, 2018
  • Phase 3 data support apixaban for cancer-associated VTE
    Publish date: December 13, 2018
  • Thrombectomy shows efficacy for basilar artery strokes
    Publish date: December 7, 2018
  • Large cohort study IDs prognostic factors in thromboangiitis obliterans
    Publish date: December 5, 2018
  • ARISTOPHANES: Apixaban edges other DOACS for octogenarians
    Publish date: December 2, 2018
more

Commentary

  • NOACs outpace warfarin for afib anticoagulation
    Publish date: September 21, 2016
  • The pros and cons of novel anticoagulants
    Publish date: September 9, 2015
  • Better stroke treatment moves tantalizingly within reach
    Publish date: March 1, 2015
  • Treating VTE in patients with gynecologic malignancies
    Publish date: February 6, 2015
  • VIDEO: Smartphone ECG detects atrial fibrillation
    Publish date: October 3, 2014
more

Multimedia

  • ARISTOPHANES: Apixaban edges other DOACS for octogenarians
    Publish date: December 2, 2018
  • VIDEO: Screening ECG patch boosts AF diagnoses ninefold
    Publish date: April 17, 2018
  • VIDEO: Rivaroxaban plus aspirin halves ischemic strokes
    Publish date: February 5, 2018
more

Topics

  • Acute Coronary Syndromes
  • Arrhythmias & EP
  • DVT/VTE
  • Fast Facts Friday

We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.

Whitelist MDedge.com
Close

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2019 Frontline Medical Communications Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer and privacy policy.

click me
Menu Menu Presented by
  • Register or Login
Menu Close
Register or Login
  • Acute Coronary Syndromes
  • Arrhythmias & EP
  • Conference Coverage
  • Multimedia

More

  • About Us